Clinical Smarter Trials

Clinical development today takes longer, and it costs more. R&D productivity is declining. Pipelines are thinner. New regulatory demands are adding another layer of complexity.

In fact, the entire development and marketing process has grown more complex—at just the moment when scrutiny from policymakers, payers and patients has increased.

In this environment, every decision, every dollar and every delay matters. This is the New Health.

Today, biopharma companies need to find greater efficiencies within existing strategies—and they want to find new strategies for success. More biopharma companies are streamlining their operations, focusing in on core competencies. And more are engaging outside resources much earlier and more strategically to achieve the outcomes they want.

Quintiles is working with customers to push both frontiers—to find new efficiencies within the existing clinical trial framework, and to forge new models for clinical development.